Xifaxan He denied due to quantity / dose limits by Cigna?
Quantity-limit denials usually flip when the appeal documents the clinically appropriate dose for the patient's weight, kidney function, or escalation schedule, citing the FDA label or specialty-society guideline.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Cigna typically requires
Cigna's specific coverage criteria for xifaxan he are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Cigna angle on Xifaxan He
## Why Cigna Applied a Quantity Limit
A quantity-limits denial for rifaximin (Xifaxan) for hepatic encephalopathy (HE) means Cigna has approved the drug but capped the quantity dispensed per prescription or per time period. The specific quantity Cigna allows is defined in their formulary and quantity-limit policy — your pharmacy benefits summary or Cigna's published drug list will show the limit applied to your plan.
Quantity limits are applied formulaically, often without individual clinical review. They become a problem when your prescriber's clinical judgment calls for a quantity, frequency, or supply duration that exceeds that administrative cap. When that happens, a quantity-limit exception is the appropriate remedy.
## Why This Is Appealable
- Exception for clinical need: Plans must allow exceptions to quantity limits when the standard limit is clinically insufficient for a specific patient. Your prescriber's documentation of your individual clinical need is the core of this appeal.
- ACA §2719 external review: If the internal appeal is denied, you can escalate to independent external review. The external reviewer determines whether the quantity limit as applied to your case was clinically reasonable. You generally have approximately four months from the denial notice; confirm the exact deadline on your EOB.
- ERISA §503: The plan must supply the criteria used and allow you to submit clinical evidence in rebuttal.
- Expedited review: Available if the standard timeline would seriously harm your health — relevant here if running out of medication poses an acute risk given your HE status.
## Documentation to Gather
- Prescriber's quantity-exception letter: Your physician should document the clinical basis for the prescribed quantity — your HE severity, the treatment course required, and why the plan's standard quantity limit does not meet your medical needs. This letter should reference the FDA-approved prescribing label as the basis for the prescribed regimen.
- FDA label reference: The prescribing information for rifaximin (available at DailyMed) describes the approved dosing regimen. Your appeal should note when the prescribed quantity aligns with or is consistent with that labeling.
- Diagnosis and severity records: Chart documentation of your HE diagnosis, episode history, and current clinical status that supports the quantity your prescriber has ordered.
- Cigna's quantity-limit policy: Obtain the specific limit Cigna applied from their formulary or drug list. Confirm your appeal addresses why that limit is insufficient for your individual case.
## Criteria-Mapping Approach
Identify the exact quantity cap from Cigna's published drug list or quantity-limit policy. Compare it with the quantity your prescriber ordered. In your appeal, document the specific clinical reason the standard limit falls short for you — tied to your HE diagnosis, severity, and the prescribing label — and ask the reviewer to grant an exception for the medically necessary quantity. A direct, documented justification for the gap between the limit and the prescribed amount is the most efficient path to reversal.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →